The number of studies reporting antimicrobial resistance (AMR) data has increased in Africa, South and South East Asia according to new research in the International Journal of Infectious Diseases.

New research using WWARN-hosted clinical trial data on tafenoquine, a newly licensed antimalarial drug for radical cure of Plasmodium vivax malaria, finds that higher doses are needed to cure infection. Join our expert discussion on whether we are getting the dosing right.

A new WWARN meta-analysis commissioned by the World Health Organization (WHO) which informed a change to its treatment guidelines* has been published in The Lancet. The study provides compelling evidence that artemether-lumefantrine should now replace quinine as the treatment of choice in the first ...

IDDO’s Director Professor Philippe Guérin has been awarded the ASTMH Distinguished International Fellow at this year’s conference in Seattle, USA.

It is with great sadness that IDDO has learnt of the passing of Professor Mamadou Pathé Diallo, a valued member of the IDDO team since 2019. Professor Diallo had been a Professor of Paediatrics since 1988 and was the Head of the Medical Centre & Health Counselling (CEMECO) in Kipé, the Paediatric, H...

It was great to welcome researchers Vijayakumar Balakrishnan (ICMR-VCRC), Hemant Mahajan (ICMR-RMRIMS) to IDDO to update on their work across malaria, visceral leishmaniasis, and filariasis.

IDDO’s Medicine Quality Research Group delivered in-person training in researchers in Mozambique and Ghana to support a study into the quality of three antibiotics.

Come and meet us at this year’s ASTMH 71st Annual Meeting - the first fully in-person meeting since 2019. Thousands of delegates are expected to attend with leading global health researchers from more than 111 countries around the world. During the conference we have several posters, talks, meetings...

Join IDDO and WWARN Director, Professor Philippe Guérin at this year’s RSTMH’s Annual Meeting where he will be discussing topical issues in malaria and in resistance with a wide range of speakers and panellists.

A new WWARN study, published in BMC Medicine, supports a World Health Organization (WHO) recommendation that a single primaquine target dose of 0.25 mg/kg is generally safe and well tolerated when given together with an ACT to treat malaria. 

In the first published study of its kind, a new WWARN paper in the Malaria Journal has created near-real-time maps to support antimalarial drug resistance monitoring, using routine malaria surveillance data and individually patient linked data on molecular markers of antimalarial drug resistance.

New studies suggest that substandard and falsified (SF) antimicrobials, in particular antibiotics, are widely spread with higher prevalence in low-and middle-income countries (LMIC). The quality of the evidence available in the scientific literature is poor but the issue has significant risks for On...

Researchers have created a mathematical model to predict genetic resistance to antimalarial drugs in Africa to manage one of the biggest threats to global malarial control.

The Medicine Quality Research Group organised a multidisciplinary hybrid meeting at Keble College, Oxford, July 3 to 6, for the FORESFA project ‘Forensic epidemiology and impact of substandard and falsified antimicrobials on public health’, funded by a Wellcome Collaborative Award.

Patients affected by COVID-19 should be treated according to the severity of their disease. However, new research out today finds that not all key national or international organisations define severity in the same way.

Taking place in Cartagena, Colombia, the WordLeish7 Conference reunites the visceral leishmaniasis (VL) scientific and research community in-person for the first time in four-years.

Microscopic examination of Giemsa-stained blood films is key to quantifying and detecting malaria parasites but there can be difficulties in ensuring both a high-quality manual reading and inter-reader reliability. The EasyScan GO was developed as a potential solution to this, a microscopy device us...

Find out more about what we’ve been up to in our latest newsletter. There are updates on our COVID-19 research, including our collaboration with ISARIC, which has assembled the world’s largest global database on COVID-19 clinical data.

Drug-resistant malaria is now a critical public health emergency on a global scale. In a new editorial a diverse group of malaria researchers, including WWARN senior scientists, have highlighted that the artemisinin confirmed recently in Rwanda and Uganda is likely just the ‘tip of the spear’, with ...

Hear from our Director, Professor Philippe Guérin, at the Geneva Health Forum’s plenary roundtable on 4 May on “Data sharing in the time of COVID-19: What works and what we need”.